Lexington, MA, United States of America

Claudia Ordonez

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Keros Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudia Ordonez. Retrieved from https://idiyas.com/inventor/claudia-ordonez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Claudia Ordonez: Innovator in Iron Overload Treatment

Introduction

Claudia Ordonez is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of medical treatments, particularly in addressing iron overload conditions. Her innovative approaches have the potential to improve the quality of life for many individuals suffering from this condition.

Latest Patents

Claudia holds a patent for "Methods of treating iron overload with a BMP inhibitor." This invention features methods of treating iron overload in a subject by administering BMP or hepcidin inhibitors, such as ALK2 inhibitors. Additionally, the invention includes methods of decreasing iron levels in a subject by administering these inhibitors.

Career Highlights

Claudia Ordonez is currently associated with Keros Therapeutics, Inc., where she continues to advance her research and development efforts. Her work focuses on innovative solutions that target critical health issues, showcasing her dedication to improving patient outcomes.

Conclusion

Claudia Ordonez is a trailblazer in the field of medical innovation, particularly in the treatment of iron overload. Her contributions through her patent and work at Keros Therapeutics, Inc. highlight her commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…